For: | Neokosmidis G, Cholongitas E, Tziomalos K. Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? World J Gastroenterol 2021; 27(39): 6522-6526 [PMID: 34754150 DOI: 10.3748/wjg.v27.i39.6522] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i39/6522.htm |
Number | Citing Articles |
1 |
Pradeep Kayampilly, Nancy Roeser, Thekkelnaycke M Rajendiran, Subramaniam Pennathur, Farsad Afshinnia. Acetyl Co-A Carboxylase Inhibition Halts Hyperglycemia Induced Upregulation of De Novo Lipogenesis in Podocytes and Proximal Tubular Cells. Metabolites 2022; 12(10): 940 doi: 10.3390/metabo12100940
|
2 |
Pervej Alom Barbhuiya, Saikat Sen, Manash Pratim Pathak. Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review. Phytochemistry Reviews 2023; doi: 10.1007/s11101-023-09912-w
|
3 |
Abdelilah Arredouani. Lifestyle-Related Diseases and Metabolic Syndrome. 2022; doi: 10.5772/intechopen.106445
|
4 |
Qin Yuan, Qianqian Zhou, Nanlan Wang, Yuancui Zheng, Hua Hu, Shiyao Hu, Huiqun Wang. Integrative proteomics and metabolomics of Guizhou Miao Sour Soup affecting simple obese rats. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1019205
|